Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - A neurophysiological study

Giorgio Sandrini, Cristina Tassorelli, Alberto Proietti Cecchini, Enrico Alfonsi, Giuseppe Nappi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce analgesia mainly via the inhibition of cyclo-oxygenase. Several reports suggest that chronic pain is mediated by central sensitization, an N-methyl-D-aspartate (NMDA)-mediated phenomenon influenced by cyclo-oxygenase activity and nitric oxide (NO). In this double-blind study, we evaluated the effects of a preferential inhibitor of the inducible isoform of cyclo-oxygenase-2, nimesulide, on the spinal nociceptive flexion reflex (RIII reflex) before and after administration of an NO donor in healthy volunteers. Nimesulide caused a reduction of the RIII reflex area, which persisted after NO donor administration. Conversely, in the placebo group the RIII reflex area significantly increased following the administration of the NO donor. These data suggest a central effect for nimesulide, possibly related to a reduction of nociceptive activity at spinal level.

Original languageEnglish
Pages (from-to)259-262
Number of pages4
JournalEuropean Journal of Pharmacology
Volume450
Issue number3
DOIs
Publication statusPublished - Aug 30 2002

Fingerprint

nimesulide
Hyperalgesia
Reflex
Nitric Oxide Donors
Nitric Oxide
Prostaglandin-Endoperoxide Synthases
Central Nervous System Sensitization
N-Methylaspartate
Double-Blind Method
Chronic Pain
Analgesia
Healthy Volunteers
Protein Isoforms
Anti-Inflammatory Agents
Placebos
Pharmaceutical Preparations

Keywords

  • Cyclo-oxygenase
  • Nimesulide
  • Nitric oxide (NO)
  • Pain
  • RIII threshold

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - A neurophysiological study. / Sandrini, Giorgio; Tassorelli, Cristina; Cecchini, Alberto Proietti; Alfonsi, Enrico; Nappi, Giuseppe.

In: European Journal of Pharmacology, Vol. 450, No. 3, 30.08.2002, p. 259-262.

Research output: Contribution to journalArticle

@article{c576fa3262cb4e748cb03838cdf19f00,
title = "Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - A neurophysiological study",
abstract = "Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce analgesia mainly via the inhibition of cyclo-oxygenase. Several reports suggest that chronic pain is mediated by central sensitization, an N-methyl-D-aspartate (NMDA)-mediated phenomenon influenced by cyclo-oxygenase activity and nitric oxide (NO). In this double-blind study, we evaluated the effects of a preferential inhibitor of the inducible isoform of cyclo-oxygenase-2, nimesulide, on the spinal nociceptive flexion reflex (RIII reflex) before and after administration of an NO donor in healthy volunteers. Nimesulide caused a reduction of the RIII reflex area, which persisted after NO donor administration. Conversely, in the placebo group the RIII reflex area significantly increased following the administration of the NO donor. These data suggest a central effect for nimesulide, possibly related to a reduction of nociceptive activity at spinal level.",
keywords = "Cyclo-oxygenase, Nimesulide, Nitric oxide (NO), Pain, RIII threshold",
author = "Giorgio Sandrini and Cristina Tassorelli and Cecchini, {Alberto Proietti} and Enrico Alfonsi and Giuseppe Nappi",
year = "2002",
month = "8",
day = "30",
doi = "10.1016/S0014-2999(02)02188-X",
language = "English",
volume = "450",
pages = "259--262",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - A neurophysiological study

AU - Sandrini, Giorgio

AU - Tassorelli, Cristina

AU - Cecchini, Alberto Proietti

AU - Alfonsi, Enrico

AU - Nappi, Giuseppe

PY - 2002/8/30

Y1 - 2002/8/30

N2 - Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce analgesia mainly via the inhibition of cyclo-oxygenase. Several reports suggest that chronic pain is mediated by central sensitization, an N-methyl-D-aspartate (NMDA)-mediated phenomenon influenced by cyclo-oxygenase activity and nitric oxide (NO). In this double-blind study, we evaluated the effects of a preferential inhibitor of the inducible isoform of cyclo-oxygenase-2, nimesulide, on the spinal nociceptive flexion reflex (RIII reflex) before and after administration of an NO donor in healthy volunteers. Nimesulide caused a reduction of the RIII reflex area, which persisted after NO donor administration. Conversely, in the placebo group the RIII reflex area significantly increased following the administration of the NO donor. These data suggest a central effect for nimesulide, possibly related to a reduction of nociceptive activity at spinal level.

AB - Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce analgesia mainly via the inhibition of cyclo-oxygenase. Several reports suggest that chronic pain is mediated by central sensitization, an N-methyl-D-aspartate (NMDA)-mediated phenomenon influenced by cyclo-oxygenase activity and nitric oxide (NO). In this double-blind study, we evaluated the effects of a preferential inhibitor of the inducible isoform of cyclo-oxygenase-2, nimesulide, on the spinal nociceptive flexion reflex (RIII reflex) before and after administration of an NO donor in healthy volunteers. Nimesulide caused a reduction of the RIII reflex area, which persisted after NO donor administration. Conversely, in the placebo group the RIII reflex area significantly increased following the administration of the NO donor. These data suggest a central effect for nimesulide, possibly related to a reduction of nociceptive activity at spinal level.

KW - Cyclo-oxygenase

KW - Nimesulide

KW - Nitric oxide (NO)

KW - Pain

KW - RIII threshold

UR - http://www.scopus.com/inward/record.url?scp=0037199693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037199693&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(02)02188-X

DO - 10.1016/S0014-2999(02)02188-X

M3 - Article

C2 - 12208318

AN - SCOPUS:0037199693

VL - 450

SP - 259

EP - 262

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -